This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
pathway Info Card
Intermediate Filament Organization
Information about Intermediate Filament Organization: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Intermediate Filament Organization
Most recent studies have shown that Intermediate Filament Organization shares some biological mechanisms with actin-cytoskeleton-organization, androgen-secretion, cell-development, cell-migration, cytokinesis, cytoskeleton-organization, liver-regeneration, localization, mitosis, mrna-transcription, oogenesis, pathogenesis, platelet-activation, platelet-aggregation, protein-phosphorylation, protein-unfolding, regeneration, secretion, tissue-morphogenesis.
Among the many pathways, these few ones have gauged particular interests from scientists studying Intermediate Filament Organization, and have been seen in publications frequently: actin-cytoskeleton-organization, androgen-secretion, cell-development, cell-migration, cytokinesis, cytoskeleton-organization, liver-regeneration, localization, mitosis, mrna-transcription, oogenesis, pathogenesis, platelet-activation, platelet-aggregation, protein-phosphorylation, protein-unfolding, regeneration, secretion, tissue-morphogenesis
Quite a number of genes have been found to play important roles in Intermediate Filament Organization, such as CALM1, CALM2, CALM3, DDC, DES, GAN, GFAP, HSPB1, KRT18, KRT20, NEFH, NEFL, NEFM, PLOD1, PRPH, VCL, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this pathway. Plesae stay updated.